Cystic fibrosis future or investigational therapies: Difference between revisions
No edit summary |
|||
Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
In cystic fibrosis therapies under investigation include prophylactic ursodiol therapy; CF corrector VX-661; inhaled dry powder | In cystic fibrosis therapies under investigation include [[Prophylaxis|prophylactic]] [[ursodiol]] therapy; CF corrector VX-661; inhaled dry powder [[mannitol]] and [[CFTR (gene)|CFTR gene]] therapy. | ||
== future or investigational therapies == | == future or investigational therapies == | ||
In cystic fibrosis therapies under investigation include:<ref name="urlCystic Fibrosis and Congenital Absence of the Vas Deferens - GeneReviews® - NCBI Bookshelf">{{cite web |url=https://www.ncbi.nlm.nih.gov/books/NBK1250/ |title=Cystic Fibrosis and Congenital Absence of the Vas Deferens - GeneReviews® - NCBI Bookshelf |format= |work= |accessdate=}}</ref> | In cystic fibrosis therapies under investigation include:<ref name="urlCystic Fibrosis and Congenital Absence of the Vas Deferens - GeneReviews® - NCBI Bookshelf">{{cite web |url=https://www.ncbi.nlm.nih.gov/books/NBK1250/ |title=Cystic Fibrosis and Congenital Absence of the Vas Deferens - GeneReviews® - NCBI Bookshelf |format= |work= |accessdate=}}</ref> | ||
* Prophylactic ursodiol therapy | * [[Prophylaxis|Prophylactic]] [[ursodiol]] therapy | ||
* CF corrector VX-661 | * CF corrector VX-661 | ||
* Inhaled dry powder mannitol | * Inhaled dry powder [[mannitol]] | ||
* CFTR gene therapy | * [[CFTR (gene)|CFTR gene]] therapy | ||
==References== | ==References== |
Revision as of 21:20, 2 March 2018
Cystic fibrosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Cystic fibrosis future or investigational therapies On the Web |
American Roentgen Ray Society Images of Cystic fibrosis future or investigational therapies |
Cystic fibrosis future or investigational therapies in the news |
Blogs on Cystic fibrosis future or investigational therapies |
Risk calculators and risk factors for Cystic fibrosis future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shaghayegh Habibi, M.D.[2]
Overview
In cystic fibrosis therapies under investigation include prophylactic ursodiol therapy; CF corrector VX-661; inhaled dry powder mannitol and CFTR gene therapy.
future or investigational therapies
In cystic fibrosis therapies under investigation include:[1]
- Prophylactic ursodiol therapy
- CF corrector VX-661
- Inhaled dry powder mannitol
- CFTR gene therapy